Gold nanoparticles could carry drugs to treat cancer, other diseases

Delivery devices already exist that can release two drugs, but the timing of the release must be built into the device — it cannot be controlled from outside the body. The new system is controlled externally and theoretically could deliver up to three or four drugs.

January 5, 2009: Ensysce Biosciences Inc., a nanotechnology company focused on the use of fullerene carbon nanotubes for therapeutic cancer applications, has appointed Dr. Lynn Kirkpatrick as president and CEO.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.